Purchase Order 12905B22P0081
Award Date 3/3/22
Potential Completion Date 2/5/23
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Emigration Canyon, UT 84108, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institutes of Health's National Center for Advancing Translational Sciences awarded a $99,000 firm fixed price purchase order to Targetmol Chemicals Inc. to synthesize analogs of repsox and intermediates from two ongoing medicinal chemistry projects. Over a six-month period after receipt of order, Targetmol will synthesize the requested compounds and deliver milligram to gram quantities to NCATS along with electronic progress reports, analytical data including LCMS and 1H NMR, and...
- The National Institutes of Health National Institute on Drug Abuse awarded a $288,375 firm fixed price purchase order to Curia Global Inc., doing business as Amri, to provide non-GMP synthesis of up to 100 ligands that bind the KIAA0203 protein. Under the terms of the contract, Amri will synthesize the ligands in 2-10 milligram quantities over a one-year period of performance. Amri must dedicate two full-time scientists and one part-time scientist at 25% effort to update progress. There is no...
- This is a $18,090.34 firm fixed-price federal contract awarded by the National Institutes of Health (NIH) Clinical Center to Ipharmasupports LLC, a small business subchapter S corporation based in Denver, Colorado. The contract is for the supply of F-DOPA synthesis sets and disposable cassettes, which are critical consumables and equipment used in biomedical research programs, particularly Positron Emission Tomography (PET) studies. Ipharmasupports LLC has established itself as a key vendor...
- The National Institute on Drug Abuse awarded a delivery order valued at $827,787.59 to Bachem Americas Inc. for the manufacture of 1 kilogram of current Good Manufacturing Practice (cGMP) L-enkephalin (L-ENK) and related contract research organization (CRO) support services for drug substance development and manufacturing. The award was issued on September 18, 2020, with an ultimate completion date of August 31, 2024. This delivery order falls under Bachem Americas' larger Indefinite...
- This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse to Novandi Chemistry AB, a manufacturer of goods. The $10,400.00 contract is for the delivery of radioactive materials, including tritium, carbon 14, and stable labeling chemistry services, to support research related to drugs of abuse. Novandi Chemistry AB has previously provided similar specialty chemicals to other NIH...
- <p>The Department of the Army Materiel Command Research Development and Engineering Command awarded a $292,500 firm fixed price definitive contract to Intelligent Material Solutions, Inc. Government Division, doing business as IMS, for research and development of distinctive micro-taggant additives. The contract will be performed in Princeton, New Jersey from January 25, 2022 through October 3, 2022. No subcontractors were identified.</p>
- This is a $760,749 firm fixed-price delivery order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health, to Societal CDMO San Diego, LLC (doing business as Irisys Inc.). The order is to provide dosage form development, manufacturing, and stability studies of the investigational drug ORC-13661 for a Phase II clinical trial. This delivery order was issued under the NCATS Drug Product Development Studies 2017-2022 indefinite...
- Curia Global Inc., doing business as Amri, has been awarded a $620,125 delivery order against the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases' Nonclinical Services for Development of Interventional Agents indefinite-delivery/indefinite-quantity contract. The delivery order is for scale-up synthesis of APX2039, a novel GWT1 enzyme inhibitor in fungi, in support of NIH's efforts to develop new treatments for...
- Cambridge Isotope Laboratories, Inc., doing business as Cambridge Isotope Labs, has been awarded a firm fixed-price purchase order valued at fifteen thousand one hundred sixty dollars by the National Institutes of Health's National Institute of Child Health and Human Development to supply deuterium oxide. The contract has a period of performance from August 2017 through August 2018 for the delivery of bottles containing 99.9% deuterium oxide to the agency's location in Andover, Massachusetts. No...
- This is a $36,000.00 firm fixed-price contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which is part of the National Institutes of Health (NIH), a civilian agency. The contract was awarded to Entrechem SL, a for-profit manufacturer located in Spain, to provide 100g each of two specialized chemical compounds, (1S,2S)-trans-N-Boc-Tetrahydro-3,4-furandiamine and (1R,2R)-trans-N-Boc-Tetrahydro-3,4-furandiamine. These compounds are needed as starting...
CUSTOM SYNTHESIS OF TWO MATERIALS, PROPOSED AND APPROVED AS AN INNOVATION FUND PROJECT. 13C- HYDROXY-IP 85MG 13C-ANILINE-IPP 85MG
Posted 3/3/22
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Close Out | ($12k) | 12/8/22 | |
| Not listed | Not listed | $23.1k | 3/3/22 |